Sort
21,453 grants matching “tuberculosis”
Novel and Optimized Diagnostics for Pediatric TB
$1,142,223Jerrold J. Ellner · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
Chemical Inhibitors to Define an Essential M. Tuberculosis Signaling Network
$1,142,013Robert N Husson · Boston Children'S Hospital · R01 · FY2013 · AI
Conditionally replicating Mycobacterium tuberculosis vaccines
$1,141,865Sabine Ehrt · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · AI
Predicting immune responses that correlate with protection against tuberculosis
$1,141,651Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · HL
Disrupting Tuberculosis Transmission: Bacterial and Host Drivers of Mycobacterium Tuberculosis Aerosolization
$1,141,359Michael Shiloh · Ut Southwestern Medical Center · R01 · FY2025 · AI
Genes And Gene Products As Immunoadjuvants
$1,140,822Steven Holland · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Therapeutics for Drug-Resistant Bacteria: Myxopyronins
$1,140,206Richard H. Ebright · Rutgers, The State Univ Of N.J. · R01 · FY2013 · AI
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$1,138,006Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Vaccine and Treatment Evaluation Units
$1,137,245Nadine Georges Rouphael · Emory University · UM1 · FY2024 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT
$1,136,119Charles H Woernle · Alabama State Dept Of Public Health · U52 · FY2014 · PS
Population Based Molecular Epidemiology of TB
$1,135,538University Of California San Francisco · R01 · FY2003 · AI
HIV/TB in Uganda: Punctuated Antiretroviral Therapy
$1,135,314Case Western Reserve University · R01 · FY2003 · AI
Miami Treatment and Prevention Clinical Trials Unit (CTU)
$1,135,209Margaret A Fischl · University Of Miami School Of Medicine · UM1 · FY2015 · AI
Pre-clinical Development of an Advanced Genexpert Test for Drug Resistant Mtb
$1,134,247David Alland · Rbhs-New Jersey Medical School · R01 · FY2017 · AI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine
$1,133,663Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AI
WaNPRC MACACA NEMESTRINA SPF BREEDING COLONY
$1,132,800University Of Washington · U24 · FY2002 · RR
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,132,476Johns Hopkins University · U01 · FY2005 · AI
Response Therapies for MDR-TB
$1,131,873Ian M Orme · Colorado State University · U01 · FY2008 · AI
Epidemiology of Mycobacterial Infections
$1,131,730D. Rebecca Prevots · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Host-Directed Therapy to Augment anti-M. tuberculosis Responses in the Setting of HIV Co-infection and to Sterilize the Tuberculoma
$1,130,921Smriti Mehra · Texas Biomedical Research Institute · R01 · FY2023 · AI
Pre-clinical Development of an Advanced Genexpert Test for Drug Resistant Mtb
$1,130,467David Alland · Rbhs-New Jersey Medical School · R01 · FY2018 · AI
Pre-clinical Development of an Advanced Genexpert Test for Drug Resistant Mtb
$1,130,467David Alland · Rbhs-New Jersey Medical School · R01 · FY2016 · AI
Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration
$1,130,415Matthias Egger · Universitat Bern · U01 · FY2006 · AI
Deep spatial immune profiling of granulomas and M. tuberculosis adaptation to disease and treatment
$1,130,293Jyothi Rengarajan · Emory University · R01 · FY2024 · AI
Human immune signatures of latent MTB infection, active disease and BCG vaccination
$1,129,462Bjoern Peters · La Jolla Institute For Immunology · U19 · FY2016 · AI